The relationship between insulin and ageing in flies could have far-reaching implications for diabetes and obesity drugs for ...

Dr Yang Liu shares his insights into the preclinical studies behind the development of drug candidates targeting the ...

Ludwig Cancer Research researchers have designed and validated a computational pipeline which integrates molecular and ...

Announced at the International Investment Summit, Lilly plan to support early-stage life sciences businesses to develop ...

A new study, presented at the United European Gastroenterology, reveals how chronic stress disturbs the balance of gut ...

Driven by a passion for early-stage scientific discovery, Cristina de Min, MD, Chief Medical Officer at Topas Therapeutics, transitioned from clinical practice to drug development.

In lab and fruit fly studies, the new peptide inhibitor effectively acted on both major aggregation-promoting hotspots of Tau proteins. Scientists at Lancaster University, University of Southampton, ...

Researchers have identified underlying KRAS mutations which drive associated risk of particular clinical outcomes. Researchers at Weill Cornell Medicine, New York-Presbyterian and Memorial Sloan ...

Sphere Fluidics have developed the Cyto-Mine® Chroma platform, which provides multiplexing and greater assay flexibility, reducing timelines and cost. On October 1, 2024, Sphere Fluidics announced ...

A deep-learning model found metabolites and drugs that could be repurposed for non-addictive and non-opioid options to treat chronic pain. Researchers at Kent State University, Cleveland Clinic and ...

Cancer Research UK-funded researchers aim to identify targets for an ovarian cancer vaccine, which could prevent the disease at an early stage. It has been announced that a new study will commence, ...